Medicalgorithmics SA stock news
Medicalgorithmics SA announced on June 22, 2026, a significant expansion of its AI research pipeline, specifically targeting automated diagnostics and population--scale cardiac prevention. The initiative leverages the company's proprietary DeepRhythmAI (DRAI) technology and its database of over 250 billion heartbeats to develop predictive analytics for the early detection of cardiac conditions. This strategic expansion is designed to provide healthcare systems and insurance providers with scalable, AI--driven tools for preventative care, moving the company's value proposition beyond traditional diagnostic services into high--growth preventative medicine sectors.